Arsenite is the most likely carcinogenic form of arsenic in the environment. Previously, expression cloning for cDNAs whose overexpression confers arsenite-resistance in Chinese hamster V79 cells identified two genes: fau and a novel gene, asr2. The fau gene encodes a ubiquitin-like protein (here called FUBI) fused to the ribosomal S30 protein. Since the expression of the fox sequence (antisense to fau) increased the tumorigenicity of a mouse sarcoma virus, it was proposed that fau might be a tumor suppressor gene. We intended to test its ability to block arsenite-induced transformation of human osteogenic sarcoma (HOS) cells to anchorage-independence. Instead, we found that overexpressing fau itself was able to transform HOS cells. When the two domains were expressed separately, only FUBI was transforming and only the S30 domain conferred arsenite resistance. An incidental finding was the transforming activity of the selectable marker, hyg. FUBI belongs to the ubiquitin-like protein group that is capable of forming conjugates to other proteins, although none have so far been identified. Alternatively, FUBI may act as a substitute or inhibitor of ubiquitin, to which it is most closely related, or to close ubiquitin-like relatives UCRP, FAT10, and/or Nedd8.
Previously, we identified two genes whose overexpression confers resistance to the human carcinogen arsenite in Chinese hamster V79 cells: the novel gene asr2 and the fau gene (Rossman and Wang, 1999) . The fau gene encodes a 133 amino-acid protein consisting of a 74 amino-acid ubiquitin-like protein (here called FUBI) fused to a 59 amino-acid ribosomal protein S30. S30 is released by post-translational cleavage of Fau and is then incorporated into the small ribosomal subunit. The fau gene was identified as the cellular homologue of the fox sequence in the Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV), originally isolated from a radiation-induced mouse osteosarcoma (Finkel et al., 1976) . The complete mouse fau cDNA sequence is inversely inserted as the fox sequence in FBR-MuSV. The expression of the fox sequence as antisense of the fau gene increases the transforming capability of FBRMuSV, presumably by inactivating fau expression (Michiels et al., 1993) . Because of this, it has been suggested that the fau gene functions as a tumor suppressor gene.
We recently found that extremely low concentrations of arsenite are able to transform nontumorigenic human osteogenic sarcoma (HOS) cells to anchorage-independence . These cells exhibit a flat morphology and can be transformed to anchorageindependence by both viral and other chemical carcinogens (Rhim et al., 1975; Rani and Kumar, 1992; Lin and Costa, 1994; Miller et al., 1998) . If fau is a tumor suppressor gene, its overexpression might be expected to inhibit transformation of these cells by arsenite and other agents. Figure 1 shows the Northern analysis of the fau expression in HOS cells and the various transfectant lines constructed. HOS cells and HOS cells transfected with pZeo vector alone show a similar level of fau expression (lanes 1 and 2). HOS cells transfected with pZeo-fau, containing full-length Chinese hamster fau cDNA, show increased fau expression, as expected (lane 3). HOS cells transfected with pZeo-FUBI and pZeo-S30, which are expected to express the ubiquitin-like domain and the S30 domain of Chinese hamster fau, respectively, show expression of faster migrating bands in addition to the normal fau band (lanes 4 and 5), consistent with expression of the domains of interest.
Overexpression of fau was previously found to confer arsenite resistance to Chinese hamster V79 cells (Rossman and Wang, 1999) . Figure 2 shows that full-length fau expression also confers arsenite-resistance to HOS cells (LC 50 ¼ 2.9 mm for the fau transfectant compared with 1.1 mm for HOS). A more modest increase in arsenite-resistance is seen in cells expressing only the S30 domain (LC 50 ¼ 1.7 mm). In contrast, expression of only the FUBI domain resulted in increased sensitivity to arsenite (LC 50 ¼ 0.4 mm). Cells transfected with vector alone show arsenite sensitivity identical to HOS (data not shown). Colony size decreases with arsenite toxicity in all cells.
HOS cells have a low (1.2 Â 10 À5 ) spontaneous transformation frequency. The pCEP-VP vector, which contains the hygromycin-resistance hyg gene as selectable marker, was found to transform HOS cells to anchorage-independence (Table 1) . Aminoglycoside phosphoryltransferases such as hyg have structural similarities to eucaryotic protein kinases, are inhibited by similar agents, and sometimes demonstrate measurable protein kinase activity (Wright et al., 1998) . In contrast, no transformation occurred when the hyg gene was replaced with zeocin-resistance as a selectable marker in pZeo. Expression of full-length fau causes significant transformation (Table 1, Figure 3 ). When its two domains are expressed separately, it is clear that the transforming activity resides in the FUBI domain (Table 1) . Four independently isolated transfectant clones expressing full-length fau and five independently isolated clones expressing its FUBI domain showed significant transforming ability, whereas none of the four independently isolated clones expressing S30 did.
In cells of the mesenchymal lineage, growth in soft agar correlates better than other criteria with the ability of a cell to grow as a tumor when injected into a suitable host (Shin et al., 1975) . Anchorage-independent activation of G 1 cyclin-dependent kinases mediates the anchorage-independent growth phenotype (Yang et al., 1998) . Although fau had been assumed to act as a tumor suppressor gene, it appears that overexpressed fau may itself have oncogenic activity. Transcription factor E2F1, which regulates cyclins A and E as well as other genes involved in cell cycle control, has also been shown to possess both oncogenic and tumor suppressor activity in different situations (Johnson, 2000) .
Most ribosomal proteins are unprocessed primary products of their mRNAs. In addition to S30, there are two other mammalian ribosomal proteins made as ubiquitin-like fusion proteins: rpS27a and rpL40 (Finley (Rossman and Wang, 1999) . The hyg gene and the HSV-1 TK promoter were cut at the Nar1 and RsrII sites. A zeocin cassette, containing the SV40 promoter, EM-7 promoter, zeocin resistance gene (zeo), and SV40 polyadenylation sequences, was PCR amplified from pcDNA4/HisMaxA (Invitrogen, San Diego, CA, USA) with Nar1/RsrII sites and cloned into pCEP-VP. The fau cDNA in pCEP-VP was digested with Nar1 and RsrII and inserted into pZeo. The FUBI domain (a 217 base pair fragment) and the S30 domain (a 205 base pair fragment) of the fau gene were separately PCR amplified using the following primers: FUBI: 5 0 GTCGGTACCATGCAGCTCTTTGT and 3 0 CCTACATGCGA CCAGCTACT. S30: 5 0 GGTACCATGTTGGGAGGTAAAGTT and 3 0 GAAGGACTTACGCGGCGCATTA. The PCR products were cloned into pZeo and sequenced to ensure accuracy (SeqWright, Houston, TX, USA). Plasmid DNA was isolated by acidic phenol extraction (Wang and Rossman, 1994) and transfected into HOS (HOS TE85, American Type Culture Collection) by the calcium phosphate procedure (Sambrook et al., 1989) . Transformed cells were selected in medium containing 100 mg/ml Zeocin (Invitrogen, CA, USA). For Northern blot, total RNA was isolated using TRI reagent (Molecular Research Center, Inc., Cincinnati, OH, USA). Poly A + RNA was then isolated using oligo(dT)-cellulose columns (Molecular Research Center, Inc.). The RNA was electrophoresed in a 1.5% agarose gel containing 3.5% formaldehyde, transferred onto a nylon membrane and hybridized to 32 Plabelled fau and human G3PDH (housekeeping gene) probes (High Prime kit, Roche). The mRNA was detected using Genestorm phosphoimager (Molecular Dynamics) , 1996) . The function and fate of FUBI is poorly understood. Although FUBI is clearly diverged from ubiquitin, it is thought to perform a similar chaperone function, facilitating incorporation of the 30S protein into ribosomes (Hochstrasser, 2000) . We have demonstrated that overexpression of the S30 domain of fau confers arsenite resistance, although full arsenite resistance might require expression of complete fau (Figure 2 ). Besides its role in ribosome biosynthesis, Fau has been identified as a subunit of the monoclonal nonspecific immune suppressor factor (MNSF) (Nakamura et al., 1995) , and its FUBI domain is responsible for this activity (Nakamura et al., 1996) . MNSF is a lymphokine excreted by murine T cell hybridomas (Nakamura and Tanigawa, 1999) . Fau was also identified as an antimicrobial protein, ubiquicidin, appearing in an interferon-g-treated macrophage cell line (Hiemstra et al., 1999) , but it is not known which domains are required for this activity.
Modification of proteins by ubiquitin is critical for targeting those proteins for degradation by the ATPdependent 26S proteosomes. Degradation of proteins to control their abundance is of importance in many cellular events (Hochstrasser, 1996) . In addition to signaling proteins for degradation, ubiquitination sometimes functions independently of proteosome action in cellular regulation without degradation (Hochstrasser, 1996) . Arsenite has been shown to inhibit two steps in the ubiquitin pathway to protein degradation (Klemperer and Pickart, 1989) , but the concentration needed was high.
A number of ubiquitin-like (ubiL) proteins with diverse functions have been identified (Jentsch and Pyrowolakis, 2000; Yeh et al., 2000) . One group, ubiquitin domain proteins, consists of proteins with Nterminal ubiquitin-like domains that do not bind to other proteins. Proteins in the second group, the ubiL modifiers, are able to form conjugates with other proteins. These include small ubiquitin-related modifier-1 (SUMO-1), neural precursor cell expressed developmentally downregulated-8 (Nedd8), ubiquitin cross-reactive protein (UCRP, also called ISG15), which has two ubiL domains, and FAT10, formerly called diubiquitin, which also has two ubiL domains. As shown in Figure 4 , human FUBI has the highest homology to ubiquitin (59%) followed by UCRP II (C-terminal domain; 57% in the aligned region), and FAT10 I (N-terminal domain; 52% in the aligned region). Homology between SUMO-1 and FUBI is much lower (26%) and is not shown. Human FUBI is 97% homologous to Chinese hamster FUBI (not shown).
UCRP is an interferon-inducible cytokine, released from a number of different cells, which induces Potter et al., 1999) . After proteolytic processing to remove a C-terminal tail, it is released either as a monomer or conjugated to other proteins (Loeb and Haas, 1992) . UBE1L, the activating enzyme for UCRP, was found lacking in lung tumor cell lines, suggesting that decreased UCRP conjugation may contribute to carcinogenesis (McLaughlin et al., 2000) . UCRP was identified in a screen for p53 and radiationinducible genes . p53 was found to be essential for induction of UCRP by dsRNA but not by interferon (Hummer et al., 2000) . Arsenite interferes with p53 functioning (Vogt and Rossman, 2001) . UCRP is also inducible by genotoxic agents (Hermeking et al., 1997) , perhaps as a result of faulty transcription on a damaged template resulting in dsRNA production (Tornaletti and Hanawalt, 1999) as well as p53 activation.
FAT10, is constitutively expressed in thymus and spleen, but can be induced by TNF a and interferon g (but not a) in many tissues (Liu et al., 1999) . Stable expression of FAT10 and its conjugation to other proteins leads to apoptosis (Raasi et al., 2001) . FAT10 also binds noncovalently to MAD2 (Liu et al., 1999) , a protein that binds to unattached kinetochores in mitotic cells and is thought to cause delay of ana phase until kinetochores are attached to the spindle (Chen et al., 1996; Li and Benezra, 1996) . Arsenite treatment has been shown to perturb spindle dynamics resulting in aneuploidy (Ramirez et al., 1997; Huang and Lee, 1998) .
NEDD8 conjugates proteins that are found mostly in the nucleus, such as cullins (Hori et al., 1999) . Cullins are essential components of SCF and VEC ubiquitin ligases (Tateishi et al., 2001 ) that ubiquinate such important proteins as the cell cycle inhibitor and tumor suppressor p27(Kip1) (Podust et al., 2000) and IkB, the inhibitor of the transcription factor NF-kB, resulting in NF-kB activation (Read et al., 2000) . Arsenite (at toxic concentrations) also induces NF-kB activation (Huang et al., 2001) . NEDD8 modification also regulates cell cycle progression and the cytoskeletin (Kurz et al., 2002) .
This second class of ubiL-containing proteins contains (or is processed to contain) a free C-terminal gly gly needed for protein conjugation with the e-amino group of lysine residues on other proteins. FUBI also has a C-terminal gly-gly residue (Figure 4) suggesting that FUBI might also take part in protein modification, although this has not yet been established. FUBI-lation of proteins, should it exist, might represent a unique type of protein modification. Alternatively, FUBI may be able to substitute for or inhibit the ubiL proteins FAT10, Nedd8 or UCRP, or ubiquitin itself, for which it has high homology ( Figure 4) . The possibility that FUBI might interfere with other ubiquitin-containing proteins, including ubiquitin domain proteins, cannot be ruled out.
